Cargando…
Management of high-risk and advanced basal cell carcinoma
Despite that basal cell carcinoma (BCC) is curative in the vast majority of cases, some patients are at high risk of recurrence and, in a few patients, lesions can progress to a point unsuitable for local therapy and prognosis is quite poor. The aim of the present work is to review clinical and path...
Autores principales: | Puig, S., Berrocal, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495248/ https://www.ncbi.nlm.nih.gov/pubmed/25643667 http://dx.doi.org/10.1007/s12094-014-1272-9 |
Ejemplares similares
-
Advances in the management of basal cell carcinoma
por: Lewin, Jesse M., et al.
Publicado: (2015) -
Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
por: Chen, Olivia M., et al.
Publicado: (2022) -
Update on the Management of Basal Cell Carcinoma
por: BASSET-SEGUIN, Nicole, et al.
Publicado: (2020) -
Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives
por: Heppt, Markus V., et al.
Publicado: (2022) -
Emerging concepts and recent advances in basal cell carcinoma
por: Totonchy, Mariam, et al.
Publicado: (2017)